Quick Answer
Oaktree Acquisition Corp. III Life Sciences reported Operating Income of -$1.20 million for fiscal year 2025.
Oaktree Acquisition Corp. III Life Sciences Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$1.20M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$225.6K | -369.0% | +16.4% |
| June 30, 2025 | -$269.8K | — | +39.3% |
| March 31, 2025 | -$444.8K | — | -824.8% |
| September 30, 2024 | -$48.1K | — | — |
- The most recent figure is from Oaktree Acquisition Corp. III Life Sciences’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: